Pacira Pharmaceuticals, Inc. v. Research Development Foundation

District Court, D. Nevada·Decided September 19, 2024·No. 2:21-cv-02241·Unknown

Opinion

1 2 UNITED STATES DISTRICT COURT DISTRICT OF NEVADA 3 4 Pacira Pharmaceuticals, Inc., Case No. 2:21-cv-02241-CDS-NJK

5 Plaintiff Order Resolving RDF’s Motion in Limine to Exclude Opinions and Testimony 6 v. of Brian P. Jenkins

7 Research Development Foundation, [ECF No. 222, 253]

8 Defendant

9 10 Plaintiff Pacira Pharmaceuticals, Inc. sues defendant Research Development Foundation 11 (“RDF”) in this declaratory-judgment action arising out of a long-standing assignment 12 agreements between the parties. RDF filed a motion in limine seeking to exclude parts of the 13 expert testimony of Pacira’s expert witness Brian P. Jenkins. RDF motion, ECF No. 222 (sealed); 14 ECF No. 253 (unsealed). Pacira opposes the motion. Opp’n, ECF No. 261. RDF filed a reply to 15 Pacira’s opposition. RDF Reply, ECF No. 284. For the reasons described herein, I grant in part 16 and deny in part RDF’s motion in limine to exclude the testimony of Dr. Jenkins. 17 I. Legal standard 18 The court incorporates the motion in limine standard set forth in the order resolving 19 Pacira’s motions in limine to exclude, ECF No. 307. 20 II. Discussion 21 As background, the issues that remain outstanding for trial are: (1) “whether Pacira’s 22 New Patents ‘relate to the Assigned Proprietary Property’ under Section 3.8 of the 1994 23 Agreement[,]” ECF No. 232 (citing ECF No. 178 at 6); ECF No. 264 at 4 (citing Summ. J. Order, 24 ECF No. 152 at 17–18), and (2) unenforceability of the assignment agreements on the grounds of 25 unconscionability and public policy, ECF No. 232 at 6. 26 1 In his expert report, Jenkins discusses RDF’s royalty revenues related to Pacira as a 2 percentage of RDF’s total royalty revenues; compensation paid to RDF representatives Thomas 3 J. Brorby, Dudley R. Dobie, and Brian W. Crozier by RDF and related organizations; and fees 4 incurred by the law firm of Brorby, Crozier & Dobie, P.C. for legal services provided to RDF and 5 related organizations. See Jenkins rep., ECF No. 253-2. RDF seeks exclusion of Jenkins’s report 6 and testimony arguing that his report does not assist the trier of fact and is irrelevant to the 7 remaining issues set for trial. ECF No. 253 at 7–19. 8 A. Whether Jenkins’s report assists the trier of fact1 9 RDF argues first that Jenkins’s report essentially boils down to three tables which 10 summarize information available to the factfinder and for which he conducts only basic addition 11 and division. Id. at 7. It contends that the conclusions he offers could be drawn by a layperson 12 and require no specialized skills. Id. at 13 (citing Ga. Operators Self-Insurers Fund v. PMA Mgmt. Corp., 13 143 F. Supp. 3d 1317, 1338 (N.D. Ga. 2015) and Isr. Travel Advisory Serv. v. Isr. Identity Tours, 1993 U.S. 14 Dist. LEXIS 13749, at *4–6 (N.D. Ill. Sep. 15, 1993)). In its response, Pacira argues that Jenkins’s 15 opinions are helpful because, even if the outputs require only simple addition and division, 16 Jenkins’s inputs were complicated and required significant experience and expertise. ECF No. 17 261 at 15–20. Pacira contends that, (1) for his royalty reports, Jenkins reviewed thousands of 18 pages of forms to put together a picture of RDF’s royalty revenue; (2) for his table analyzing 19 RDF payments to Brorby, Crozier, and Dobie, he was required to derive annual compensation 20 paid to each RDF Trustee for the period from 2001 through 2020; and (3) for his legal fees table, 21 he compiled and analyzed tax returns from five entities across nineteen years. Id. at 16–18. 22 “Whether the situation is a proper one for the use of expert testimony is to be 23 determined on the basis of assisting the trier” and “[t]here is no more certain test for 24 determining when experts may be used than the common sense inquiry whether the untrained 25 26 1 As the parties are aware, because this is a bench trial, I will be serving as the trier of fact. 1 layman would be qualified to determine intelligently and to the best possible degree the 2 particular issue without enlightenment from those having a specialized understanding of the 3 subject involved in the dispute.” Fed. R. Evid. 702 advisory committee’s note (citations omitted). 4 However, an expert report that relies on relatively simple calculations may nonetheless assist 5 the trier of fact where the basis for these calculations is “more involved[.]” Relevant Grp., LLC v. 6 Nourmand, 2022 WL 18356631, at *4 (C.D. Cal. Dec. 9, 2022); cf. SiteLock LLC v. GoDaddy.com LLC, 7 562 F. Supp. 3d 283, 331 (D. Ariz. 2022) (finding that even though an expert was only making a 8 “simple math calculation[,]” it could still be useful to the trier of fact). 9 I find that, even though Jenkins only conducts addition and division in his calculations, 10 his expertise as an accountant is essential in both reaching and evaluating those calculations; 11 especially calculations that involve calculations that span over the course of nineteen years. 12 Although a layperson could find an average, a layperson would not have been able to evaluate 13 the thousands of documents upon which Jenkins relied to synthesize the numbers he calculated. 14 Accounting experts, especially, are often asked to synthesize heavy evidentiary records and 15 excluding their reports and testimony as unhelpful because their ultimate calculations are 16 “simple” misunderstands the value of their expertise. Therefore, RDF’s motion to exclude 17 Jenkins’s testimony because it is unhelpful to the trier of fact is denied without prejudice. 18 B. Relevance of Jenkins’s report 19 RDF argues that all parts of Jenkins’s report are irrelevant. 20

21 RDF first argues that Jenkins’s Pacira royalty revenues opinions are irrelevant because 22 they do not serve to address the question of whether the ’495 patent and the ’572 or ’838 patents 23 are related, and are frivolous to any bias question because, although a fact witness could testify 24 that RDF receives royalties from Pacira, the amount in royalties is irrelevant. ECF No. 253 at 14– 25 15. It expresses concern that this bias testimony will lead to a “mini-trial on, or an attempt to 26 quantify, a party’s or its representative-witnesses’ inherent partiality.” Id. at 15 (citing Dent v. U.S. 1 Tennis Ass’n, 2010 U.S. Dist. LEXIS 31052, at *2–3 (E.D.N.Y. Mar. 30, 2010)). In response to this 2 contention, Pacira argues that Jenkins’s testimony is relevant because it demonstrates RDF’s 3 “significant financial stake in the outcome of this litigation[,]” which would not come to light 4 otherwise. ECF No. 261 at 21. Additionally, it argues that the royalty revenue opinions are 5 relevant to the substantive unconscionability question, “as it speaks to the ‘one sidedness’ of the 6 contract under RDF’s ‘harsh’ and ‘unreasonable’ interpretation.” Id. at 22. (citing D.R. Horton, Inc. 7 v. Green, 96 P.3d 1159, 1163–64 (2004) (“substantive unconscionability focuses on the one- 8 sidedness of the contract terms.”) (quoting Ting v. AT&T, 319 F.3d 1126, 1149 (9th Cir.), cert. denied, 9 540 U.S. 811 (2003))). 10 I agree that Jenkins’s opinions about the Pacira royalty revenue are relevant. Evidence of 11 potential bias, as well as the extent of that bias, may be relevant. See, e.g., Heath v. Cast, 813 F.2d 12 254, 259 (9th Cir. 1987) (finding that factfinder was “entitled to hear the evidence and decide 13 the extent of that bias”); see also United States v. Abel, 469 U.S. 45

Free access — add to your briefcase to read the full text and ask questions with AI

Pacira Pharmaceuticals, Inc. v. Research Development Foundation, (D. Nev. 2024).

Pacira Pharmaceuticals, Inc. v. Research Development Foundation (Pacira Pharmaceuticals, Inc. v. Research Development Foundation) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

United States v. Abel
469 U.S. 45 (Supreme Court, 1984)
Robert Brennan v. Michael J. Cunningham, Etc.
813 F.2d 1 (First Circuit, 1987)
Georgia Operators Self-Insurers Fund v. PMA Management Corp.
143 F. Supp. 3d 1317 (N.D. Georgia, 2015)